Azor and Q10 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azor (amlodipine besylate; olmesartan medoxomil) and Q10 (coenzyme q - 10). Common drug interactions include depression among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Azor and Q10. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

What is Q10?

Q10 has active ingredients of coenzyme q - 10. eHealthMe is studying from 34,257 Q10 users. Check the latest studies of Q10.

On May, 01, 2026

36 people who take Azor and Q10 together, and have interactions are studied.

What are the common drug interactions of Azor and Q10, by gender? *:

female:

Depression
Psoriasis (immune-mediated disease that affects the skin)
Decreased interest
Depressed mood
Aphasia (damage to the parts of the brain that control language)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Constipation
Diarrhoea
Drug ineffective
Dry eye (lack of adequate tears)

male:

Chronic kidney disease
Deafness
Fatigue (feeling of tiredness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Dehydration (dryness resulting from the removal of water)
Erythema (redness of the skin)
Gout (uric acid crystals building up in the body)
Oedema peripheral (superficial swelling)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

What are the common drug interactions of Azor and Q10, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Asthenia (weakness)
Dizziness
Erectile dysfunction
Fatigue (feeling of tiredness)

50-59:

Psoriasis (immune-mediated disease that affects the skin)
Eye infection

60+:

Deafness
Drug ineffective
Dehydration (dryness resulting from the removal of water)
Dizziness
Dyspepsia (indigestion)
Erythema (redness of the skin)
Gout (uric acid crystals building up in the body)
Injection site pain
Injection site papule (solid pimple or swelling at injection site)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

What are the existing conditions these people have? *

Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 7 people, 19.44%
Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 13.89%
Psoriasis (immune-mediated disease that affects the skin): 4 people, 11.11%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 11.11%
Hypersensitivity: 4 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 11.11%
Spinal Cord Compression: 3 people, 8.33%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 3 people, 8.33%
Neuropathy Peripheral (surface nerve damage): 3 people, 8.33%
High Blood Cholesterol: 3 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Azor and Q10?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously